ConductScience.org, home

Paper77475

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Salmon SE and 5 others. N Engl J Med, 1978. Cited by 1,068 papers, by iCite.

Cite this record

ConductScience Library. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. Papers, record 77475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
PubMed
Journal
N Engl J Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,068
iCite
Relative citation ratio, by iCite
34.4
iCite
Revised in PubMed
2022-04-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salmon SES E
2Hamburger AWA W
3Soehnlen BB
4Durie BGB G
5Alberts DSD S
6Moon TET E

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Clone CellsMajor topic
Hematopoietic Stem CellsMajor topic
Bleomycin
Carmustine
Doxorubicin
Drug Resistance
Female
Humans
Melphalan
Methotrexate
Multiple Myeloma
Ovarian Neoplasms
Prognosis
Prospective Studies
Retrospective Studies
Vinblastine

Source PubMed

Download CSV of topics

Cited by242

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,068 citations.

PMIDTitleJournalYearIn PapersSource
41695491From 2D cultures to 3D systems: evolving cancer models at the interface of functional precision medicine and theranostics.Theranostics2026https://conductscience.org/library/papers/41695491PubMed
40964661Advances and challenges in human 3D solid tumor models.Adv Funct Mater2025https://conductscience.org/library/papers/40964661PubMed
40873434Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40873434PubMed
39861111Pharmaceutical Humanities and Narrative Pharmacy: An Emerging New Concept in Pharmacy.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/39861111PubMed
38040674Standardized assays to monitor drug sensitivity in hematologic cancers.Cell Death Discov2023https://conductscience.org/library/papers/38040674PubMed
37852342From shape-shifting embryonic cells to oncology: The fascinating history of epithelial mesenchymal transition.Semin Cancer Biol2023https://conductscience.org/library/papers/37852342PubMed
36358633Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells.Cancers (Basel)2022https://conductscience.org/library/papers/36358633PubMed
35625628Automated-Mechanical Procedure Compared to Gentle Enzymatic Tissue Dissociation in Cell Function Studies.Biomolecules2022https://conductscience.org/library/papers/35625628PubMed
34703845Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells.Mol Ther Methods Clin Dev2021https://conductscience.org/library/papers/34703845PubMed
34646385Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.Theranostics2021https://conductscience.org/library/papers/34646385PubMed
34222745Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics.Annu Rev Cancer Biol2021https://conductscience.org/library/papers/34222745PubMed
31384612Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancer.Ann Surg Treat Res2019https://conductscience.org/library/papers/31384612PubMed
29510509Miniaturization of the Clonogenic Assay Using Confluence Measurement.Int J Mol Sci2018https://conductscience.org/library/papers/29510509PubMed
29285367
Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma.
Mol Clin Oncol2017https://conductscience.org/library/papers/29285367PubMed
28855997Collagen gel droplet-embedded culture drug sensitivity testing in hard palate cancer-predicted antitumor efficacy of cetuximab: A case report.Mol Clin Oncol2017https://conductscience.org/library/papers/28855997PubMed
28105171Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil.Oncol Lett2016https://conductscience.org/library/papers/28105171PubMed
27239797lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.Nat Struct Mol Biol2016https://conductscience.org/library/papers/27239797PubMed
27218886Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.Pharmacol Ther2016https://conductscience.org/library/papers/27218886PubMed
27145761Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients.Curr Pharm Des2016https://conductscience.org/library/papers/27145761PubMed
265495373D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation.Int J Oncol2016https://conductscience.org/library/papers/26549537PubMed

See all 242 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/77475

GET https://conductscience.org/api/papers/v1/77475/cited_by?page=2